Last reviewed · How we verify
NCT05434936
Ovarian Tissue Cryopreservation for Fertility Preservation in Girls and Women
NA trial testing Oophorectomy in Fertility Preservation in 24 participants. Suspended.
10 October 2025
Quick facts
| Lead sponsor | Baylor College of Medicine |
|---|---|
| Phase | NA |
| Status | Suspended |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 24 |
| Start date | 11 August 2017 |
| Primary completion | 10 October 2025 |
| Estimated completion | 10 October 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Oophorectomy
Conditions studied
- Fertility Preservation — all drugs for Fertility Preservation →
Sponsor
Baylor College of Medicine
Who can join
Adults 0 to 42, female only, with Fertility Preservation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will compare efficacy of ovarian tissue freezing using slow-freeze versus vitrification methods.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05434936
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Oophorectomy
Trials testing the same drug.
- NCT02760849 — Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations · NA · active not recruiting
Other recruiting trials for Fertility Preservation
Currently open trials in the same condition.
- NCT07225660 — Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive te · NA · recruiting
- NCT07077876 — Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Tre · recruiting
- NCT06175832 — PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study · Phase 4 · recruiting
- NCT06289062 — Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer · Phase 2 · recruiting
- NCT05885048 — Impact of Gonadotoxic Therapies on Fertility · recruiting
Other Baylor College of Medicine trials
Trials by the same sponsor.
- NCT07513194 — GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) · Phase 1 · not yet recruiting
- NCT05855824 — Toddler Biomarker of Nutrition Study · NA · not yet recruiting
- NCT06738628 — Disposable Endoscope Platform in Third Space Endoscopic Procedures · not yet recruiting
- NCT06834997 — Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital · Phase 2 · withdrawn
- NCT07387614 — WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOME · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05434936 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baylor College of Medicine
- Last refreshed: 18 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05434936.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing